Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg; T Kringelbach; N Bolstad; D J Warren; G Eng; I J Sørensen; A G Loft; O Hendricks; Imj Hansen; A Linauskas; H Nordin; S Kristensen; H Lindegaard; D V Jensen; G L Goll; E Høgdall; J Gehin; C Enevold; C H Nielsen; N S Krogh; J S Johansen; M L Hetland

doi:10.1080/03009742.2017.1376110

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

B Glintborg, T Kringelbach, N Bolstad, D J Warren, G Eng, I J Sørensen, A G Loft, O Hendricks, Imj Hansen, A Linauskas, H Nordin, S Kristensen, H Lindegaard, D V Jensen, G L Goll, E Høgdall, J Gehin, C Enevold, C H Nielsen, N S KroghJ S Johansen, M L Hetland

Institut for Klinisk Medicin

8 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	47
Udgave nummer	5
Sider (fra-til)	418-421
ISSN	0300-9742
DOI	https://doi.org/10.1080/03009742.2017.1376110
Status	Udgivet - 3 sep. 2018

Adgang til dokumentet

10.1080/03009742.2017.1376110

Citationsformater

Glintborg, B., Kringelbach, T., Bolstad, N., Warren, D. J., Eng, G., Sørensen, I. J., Loft, A. G., Hendricks, O., Hansen, I., Linauskas, A., Nordin, H., Kristensen, S., Lindegaard, H., Jensen, D. V., Goll, G. L., Høgdall, E., Gehin, J., Enevold, C., Nielsen, C. H., ... Hetland, M. L. (2018). Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care. Scandinavian Journal of Rheumatology, 47(5), 418-421. https://doi.org/10.1080/03009742.2017.1376110

Glintborg, B, Kringelbach, T, Bolstad, N, Warren, DJ, Eng, G, Sørensen, IJ, Loft, AG, Hendricks, O, Hansen, I, Linauskas, A, Nordin, H, Kristensen, S, Lindegaard, H, Jensen, DV, Goll, GL, Høgdall, E, Gehin, J, Enevold, C, Nielsen, CH, Krogh, NS, Johansen, JS & Hetland, ML 2018, 'Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care', Scandinavian Journal of Rheumatology, bind 47, nr. 5, s. 418-421. https://doi.org/10.1080/03009742.2017.1376110

@article{a05b34946fb64779af822bfed56a47ff,

title = "Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care",

keywords = "Adult, Aged, Antibodies/blood, Antibodies, Monoclonal/blood, Arthritis/blood, Denmark, Female, Follow-Up Studies, Humans, Infliximab/administration & dosage, Male, Middle Aged",

author = "B Glintborg and T Kringelbach and N Bolstad and Warren, {D J} and G Eng and S{\o}rensen, {I J} and Loft, {A G} and O Hendricks and Imj Hansen and A Linauskas and H Nordin and S Kristensen and H Lindegaard and Jensen, {D V} and Goll, {G L} and E H{\o}gdall and J Gehin and C Enevold and Nielsen, {C H} and Krogh, {N S} and Johansen, {J S} and Hetland, {M L}",

year = "2018",

month = sep,

day = "3",

doi = "10.1080/03009742.2017.1376110",

language = "English",

volume = "47",

pages = "418--421",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "5",

}

TY - JOUR

T1 - Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

AU - Glintborg, B

AU - Kringelbach, T

AU - Bolstad, N

AU - Warren, D J

AU - Eng, G

AU - Sørensen, I J

AU - Loft, A G

AU - Hendricks, O

AU - Hansen, Imj

AU - Linauskas, A

AU - Nordin, H

AU - Kristensen, S

AU - Lindegaard, H

AU - Jensen, D V

AU - Goll, G L

AU - Høgdall, E

AU - Gehin, J

AU - Enevold, C

AU - Nielsen, C H

AU - Krogh, N S

AU - Johansen, J S

AU - Hetland, M L

PY - 2018/9/3

Y1 - 2018/9/3

KW - Adult

KW - Aged

KW - Antibodies/blood

KW - Antibodies, Monoclonal/blood

KW - Arthritis/blood

KW - Denmark

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Infliximab/administration & dosage

KW - Male

KW - Middle Aged

U2 - 10.1080/03009742.2017.1376110

DO - 10.1080/03009742.2017.1376110

M3 - Letter

C2 - 29310493

SN - 0300-9742

VL - 47

SP - 418

EP - 421

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - 5

ER -